Aneurysms, cardiovascular disease
Conditions
Interventions
Adjust the anesthesia depth group.:Appropriate reduction of superficial anesthesia depth and the use of vasoactive drugs to ensure cerebral perfusion
Sponsors
Department of anesthesiology, Xiangya Hospital of Central South University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion: in the hospital of xiangya in 2018, the patients with the following diseases (hereinafter referred to as the cardiovascular disease) will be closed and combined with the following diseases. 1. The diagnosis of definite hypertension (SBP is greater than 130mmhg or DBP is greater than 80mmhg), with or without the history of drug control; 2. Clear diagnosis of coronary heart disease; 3. Pulmonary hypertension; 4. Congenital heart disease or structural heart disease: moderate or above valve stenosis or insufficiency; 5. Cardiomyopathy; 6. Arrhythmias: severe sinus bradycardia (HR = 50 times/min), tachycardia (more than 100 times/min), conduction block affects hemodynamics and so on.
Exclusion criteria
Exclusion criteria: 1. The combination of severe liver and kidney dysfunction requires liver and kidney transplantation or replacement therapy; 2. Refuse to participate in this study; 3. The American association of anesthesiologists is rated at level 4 and above; 4. Decreased lung function.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| GOS; | — |
Countries
China
Contacts
Public ContactCHEN Na
Xiangya Hospital of Central South University
Outcome results
None listed